Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Helder Novais e Bastos is active.

Publication


Featured researches published by Helder Novais e Bastos.


Journal of Experimental Medicine | 2016

The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells

Alejo Chorny; Sandra Casas-Recasens; Jordi Sintes; Meimei Shan; Nadia Polentarutti; Ramón García-Escudero; A. Cooper Walland; John R. Yeiser; Linda Cassis; Jorge Carrillo; Irene Puga; Cristina Cunha; Helder Novais e Bastos; Fernando Rodrigues; João F. Lacerda; António Morais; Rebeca Dieguez-Gonzalez; Peter S. Heeger; Giovanni Salvatori; Agostinho Carvalho; Adolfo García-Sastre; J. Magarian Blander; Alberto Mantovani; Cecilia Garlanda; Andrea Cerutti

Cerutti and collaborators show that the humoral arms of the innate and adaptive immune systems are functionally interconnected by pentraxin 3, a soluble pattern recognition receptor that couples innate immune recognition with antibody-inducing function.


PLOS ONE | 2016

A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis

Helder Novais e Bastos; Nuno S. Osório; António G. Castro; Angélica Ramos; Teresa Carvalho; Leonor Meira; David Araújo; Leonor M. Almeida; Rita Boaventura; Patrícia Fragata; Catarina Chaves; Patrício Costa; Miguel Portela; Ivo Ferreira; Sara Magalhães; Fernando Rodrigues; Rui Sarmento-Castro; Raquel Duarte; João Tiago Guimarães; Margarida Saraiva

Tuberculosis imposes high human and economic tolls, including in Europe. This study was conducted to develop a severity assessment tool for stratifying mortality risk in pulmonary tuberculosis (PTB) patients. A derivation cohort of 681 PTB cases was retrospectively reviewed to generate a model based on multiple logistic regression analysis of prognostic variables with 6-month mortality as the outcome measure. A clinical scoring system was developed and tested against a validation cohort of 103 patients. Five risk features were selected for the prediction model: hypoxemic respiratory failure (OR 4.7, 95% CI 2.8–7.9), age ≥50 years (OR 2.9, 95% CI 1.7–4.8), bilateral lung involvement (OR 2.5, 95% CI 1.4–4.4), ≥1 significant comorbidity—HIV infection, diabetes mellitus, liver failure or cirrhosis, congestive heart failure and chronic respiratory disease–(OR 2.3, 95% CI 1.3–3.8), and hemoglobin <12 g/dL (OR 1.8, 95% CI 1.1–3.1). A tuberculosis risk assessment tool (TReAT) was developed, stratifying patients with low (score ≤2), moderate (score 3–5) and high (score ≥6) mortality risk. The mortality associated with each group was 2.9%, 22.9% and 53.9%, respectively. The model performed equally well in the validation cohort. We provide a new, easy-to-use clinical scoring system to identify PTB patients with high-mortality risk in settings with good healthcare access, helping clinicians to decide which patients are in need of closer medical care during treatment.


Jornal Brasileiro De Pneumologia | 2015

Influence of emphysema distribution on pulmonary function parameters in COPD patients

Helder Novais e Bastos; Inês Neves; Margarida Redondo; Rui Cunha; José Miguel Pereira; Adriana Magalhães; Gabriela Fernandes

ABSTRACT OBJECTIVE: To evaluate the impact that the distribution of emphysema has on clinical and functional severity in patients with COPD. METHODS: The distribution of the emphysema was analyzed in COPD patients, who were classified according to a 5-point visual classification system of lung CT findings. We assessed the influence of emphysema distribution type on the clinical and functional presentation of COPD. We also evaluated hypoxemia after the six-minute walk test (6MWT) and determined the six-minute walk distance (6MWD). RESULTS: Eighty-six patients were included. The mean age was 65.2 ± 12.2 years, 91.9% were male, and all but one were smokers (mean smoking history, 62.7 ± 38.4 pack-years). The emphysema distribution was categorized as obviously upper lung-predominant (type 1), in 36.0% of the patients; slightly upper lung-predominant (type 2), in 25.6%; homogeneous between the upper and lower lung (type 3), in 16.3%; and slightly lower lung-predominant (type 4), in 22.1%. Type 2 emphysema distribution was associated with lower FEV1, FVC, FEV1/FVC ratio, and DLCO. In comparison with the type 1 patients, the type 4 patients were more likely to have an FEV1 < 65% of the predicted value (OR = 6.91, 95% CI: 1.43-33.45; p = 0.016), a 6MWD < 350 m (OR = 6.36, 95% CI: 1.26-32.18; p = 0.025), and post-6MWT hypoxemia (OR = 32.66, 95% CI: 3.26-326.84; p = 0.003). The type 3 patients had a higher RV/TLC ratio, although the difference was not significant. CONCLUSIONS: The severity of COPD appears to be greater in type 4 patients, and type 3 patients tend to have greater hyperinflation. The distribution of emphysema could have a major impact on functional parameters and should be considered in the evaluation of COPD patients.


Jornal Brasileiro De Pneumologia | 2015

Influência da distribuição do enfisema nos parâmetros de função pulmonar em pacientes com DPOC

Helder Novais e Bastos; Inês Neves; Margarida Redondo; Rui Cunha; José Miguel Pereira; Adriana Magalhães; Gabriela Fernandes

A distribuicao do enfisema foi analisada em pacientes com DPOC, que foram classificados de acordo com um sistema de classificacao visual de cinco pontos a partir de achados de TC de torax. Avaliou-se a influencia do tipo de distribuicao do enfisema na apresentacao funcional e clinica da DPOC. Hipoxemia apos o teste da caminhada de seis minutos (TC6) foi tambem avaliada e a distância percorrida (DTC6) foi determinada.


Frontiers in Immunology | 2018

The Troika Host-Pathogen-Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes

Helder Novais e Bastos; Nuno S. Osório; Sebastien Gagneux; Iñaki Comas; Margarida Saraiva

The already enormous burden caused by tuberculosis (TB) will be further aggravated by the association of this disease with modern epidemics, as human immunodeficiency virus and diabetes. Furthermore, the increasingly aging population and the wider use of suppressive immune therapies hold the potential to enhance the incidence of TB. New preventive and therapeutic strategies based on recent advances on our understanding of TB are thus needed. In particular, understanding the intricate network of events modulating inflammation in TB will help to build more effective vaccines and host-directed therapies to stop TB. This review integrates the impact of host, pathogen, and extrinsic factors on inflammation and the almost scientifically unexplored complexity emerging from the interactions between these three factors. We highlight the exciting data showing a contribution of this troika for the clinical outcome of TB and the need of incorporating it when developing novel strategies to rewire the immune response in TB.


Revista Portuguesa De Pneumologia | 2015

Lung transplant: Complications and quality of life

Ana Verónica Cardoso; Helder Novais e Bastos; Carla Damas

S en si tiv ity 2. Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, Fine MJ. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. s.l. ArchInternMed. 2002;162:1059--64. 3. Rabello L, Salluh J. Estratificação de gravidade na pneumonia adquirida na comunidade. s.l. Pulmão RJ. 2009; Supl 2: 26--S32. 4. Levi M, Schultz MJ, Rijneveld AW, et al. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. s.l. Crit Care Med. 2003;31 suppl:S238--42. 5. Querol-Ribelles JM, Tenias J, Grau E, Querol-Borras J, Climent J, Martinez I. Plasma d-Dimer Levels Correlate With Outcomes in Patients With Community-Acquied Pneumonia. s.l. CHEST. 2004;126:1087--92. 6. Snijders D, Schoorl M, Schoorl M, Bartels PC, Van der Werf TS,


Respiratory Care | 2015

Mechanical ventilation for the treatment of severe excessive dynamic airway collapse.

Helder Novais e Bastos; Nélson Teixeira; Margarida Redondo; Miguel Gonçalves; Maria Sucena

To the Editor: We read with interest the case report by Ismael et al[1][1] describing a patient with Sjogrens syndrome and cystic lung disease who could not be weaned from a ventilator due to severe central excessive dynamic airway collapse (EDAC) of the lower part of the trachea and proximal


Sleep and Breathing | 2016

Randomised short-term trial of high-span versus low-span APAP for treating sleep apnoea

Helder Novais e Bastos; Ana Verónica Cardoso; Ana Castro; Rita Gomes; Tiago Pinto; Anabela Marinho; Maria Sucena; João Almeida; Marta Drummond; João Carlos Winck


Archive | 2015

Excessive Dynamic Airway Collapse in the Critical Care Setting

Helder Novais e Bastos; Margarida Redondo; Sun Mr; Majid A


European Respiratory Journal | 2017

Tuberculosis severity and its association with pathogen phylogeny and properties

Helder Novais e Bastos; Henrique Machado; Jeremy Sousa; Maria Isabel Veiga; Angélica Ramos; Teresa Carvalho; Fernando Rodrigues; António G. Castro; Nuno S. Osório; João Tiago Guimarães; Margarida Saraiva

Collaboration


Dive into the Helder Novais e Bastos's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Araújo

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge